20/20 Biolabs (AIDX) vs Vivos Therapeutics (VVOS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Vivos Therapeutics is the larger company by market cap ($5.0 million vs $4.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIDX | VVOS |
|---|---|---|
| Share price | $0.379 | $0.1495 |
| Market cap | $4.84M | $5.02M |
| 1-day change | +10.33% | -0.99% |
| EPS (TTM) | $-0.75 | $-1.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.00 | $3.28 |
| 52-week low | $0.33 | $0.129 |
| Distance from 52-week high | -99.24% | -95.44% |
| Analyst consensus | none | none |
| Avg. price target upside | +1219.26% | +1318.06% |
| Average volume | 90.86K | 12.57M |
| Shares outstanding | 12.77M | 33.61M |
| Employees | 4 | 268 |
| Sector | Health Care | Health Care |
| Industry | Precision Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About 20/20 Biolabs
AIDX stock →20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Health Care · Precision Instruments · 4 employees
About Vivos Therapeutics
VVOS stock →Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
Health Care · Medical/Dental Instruments · 268 employees
AIDX vs VVOS FAQ
Which is bigger, 20/20 Biolabs or Vivos Therapeutics?
Vivos Therapeutics (VVOS) is larger, with a market capitalization of $5.02M compared with $4.84M for 20/20 Biolabs (AIDX).
Are 20/20 Biolabs and Vivos Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Precision Instruments for 20/20 Biolabs and Medical/Dental Instruments for Vivos Therapeutics.